Ireland
--:--IST
Recruiting Observational

Registry of Li Fraumeni and Li Fraumeni Like Syndromes

NCT04982744 · tracked via the Priya Life Science Italy tracker
Phase
Observational
Started
2020-07-02
Last updated
2025-11-20

Condition(s) studied

Li-Fraumeni SyndromeLi-Fraumeni-Like Syndrome

Study summary

ReLF is a retrospective and prospective registry, finalized for care and research purposes. It is articulated in main sections - strongly related and mutually dependent on each other - corresponding to different data domains: personal information, clinical data, genetic data, genealogical data, surgeries, etc. This approach has been developed to corroborate and integrate data from different resources and aspects of the diseases and to correlate genetic background and phenotypic outcomes, in order to better investigate diseases pathophysiology. Due to legal requirements, institutional directives and organizational issues, we are unable to include individuals residing outside Italy in the registry at this time. We are currently engaged in the preparation of a recruitment process for individuals residing outside Italy.

Eligibility

Sex
ALL
Min age
—
Max age
—
Healthy volunteers
No
Inclusion Criteria: * All patients affected by Li Fraumeni or Li Fraumeni Like syndromes Exclusion Criteria: * Any condition unrelated to Li Fraumeni or Li Fraumeni Like syndromes

Primary outcome measure(s)

  • Natural History and Epidemiology — Since the disease is rare, the timeframe is strictly related to patients enrolment and consequently to amount of collected data. Considering the low prevalence of this disease, the time frame is up to 10 years.
    Assessment of epidemiological information. Anthropometric data: weight in kg, height in cm. In addition, weight and height will be combined to report BMI as kg/m\^2 Clinical details of the tumor: site of the lesion, number of recurrence(s), presence/absence of metastasis, size of lesion in cm\^3 Additional clinical data: type of surgery, age at surgery in years are updated at each follow up and retrospectively (when possible). Clinical reports, medical charts and imaging are the primary source of data.

Trial sites (2)

FacilityCityRegionStatus
Irccs Istituto Ortopedico Rizzoli Bologna Emilia-Romagna Recruiting
IRCCS Istituto Ortopedico Rizzoli Bologna Emilia-Romagna Enrolling By Invitation
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04982744 on ClinicalTrials.gov ↗ ← All trials in Italy